The present invention generally relates to the fields of genetic
engineering and biochemistry. In particular, it relates to a novel method
for the production of protamine as well as to novel method for the
production of protamine as well as to novel compositions containing
protamine as active ingredient. Furthermore, it relates to the use of
said compositions for killing or inhibiting micobial cells.